Given that TUG905 increased the activation of p38, an important protein that mediates neurogenesis34, we tested whether p38 inhibition could disturb the neurogenic effect of TUG905/BDNF/IL-6 combined treatment in postnatal hypothalamic NPC (Fig. 4A). Here, IL6 is linked to nasopharyngeal carcinoma.